Ureteral metastasis from locally invasive, castrate-resistant prostate cancer: A Case report

Zachary C Janatpour; Santosh Shanmuga; Edwin Gandia; Inger L Rosner

doi:10.1016/j.eucr.2021.101780

Ureteral metastasis from locally invasive, castrate-resistant prostate cancer: A Case report

Urol Case Rep. 2021 Jul 13:39:101780. doi: 10.1016/j.eucr.2021.101780. eCollection 2021 Nov.

Authors

Zachary C Janatpour¹, Santosh Shanmuga², Edwin Gandia³, Inger L Rosner^{1

2

4}

Affiliations

¹ F. Edward Hébert School of Medicine; Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814, United States.
² Division of Urology, Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, United States.
³ Department of Pathology, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, United States.
⁴ Department of Urology, Inova Fairfax Hospital, 8081 Innovation Park Dr, Fairfax, VA 22031, USA.

Abstract

Within the text we describe a 66-year-old male with a history of prostate cancer (PCa), incidentally found to have left-sided hydronephrosis and a left ureteral lesion. Ureteroscopy was employed to visualize the lesion, a biopsy was taken, and a double J stent was placed. The lesion was of prostatic origin and the patient was subsequently started on androgen deprivation therapy (ADT). 6 months following the procedure, the patient's PSA had decreased and his hydronephrosis had resolved. We are the first to report treating a ureteral metastasis from PCa and its associated hydronephrosis solely with ADT and double J stenting, respectively.

Keywords: Castrate-resistant prostate cancer; Metastatic prostate cancer; Nephroureterectomy; Prostate cancer; Ureteral metastasis.

Published by Elsevier Inc.

Publication types

Case Reports